Article

 

TraberMaretPublicHealthHumanSciencesResponseAdultsChildren_SupportingInformation.zip Public Deposited

No preview available

Download the file

https://ir.library.oregonstate.edu/concern/articles/2514nn33t

Descriptions

Attribute NameValues
Creator
Abstract
  • Vitamin E improved liver histology in children and adults with NAFLD who participated in TONIC and PIVENS clinical trials, but with significant inter-individual variability in its efficacy. Cytochrome P450 4F2 (CYP4F2) is the major enzyme metabolizing Vit E, with two common genetic variants (V433M, rs2108622 and W12G, rs3093105) found to alter its activity. We investigated the relationship between CYP4F2 genotypes, a-tocopherol levels and histological improvement in these two trials. V433M and W12G variants were genotyped in TONIC (n = 155) and PIVENS (n = 213) DNA samples. The relationships between CYP4F2 genotypes, plasma α-tocopherol levels at baseline and weeks 48 (w48) and 96 (w96) and histological end points (overall improvement in liver histology and resolution of NASH) were investigated. As a result, the V433M genotype was significantly associated with baseline plasma α-tocopherol in the TONIC trial (p = 0.004), but not in PIVENS. Among those receiving Vit E treatment, CYP4F2 V433M genotype was associated with significantly decreased plasma α-tocopherol levels at w48 (p = 0.003 for PIVENS and p = 0.026 for TONIC) but not at w96. The w96 α-tocopherol level was significantly associated with resolution of NASH (p = 0.006) and overall histology improvement (p = 0.021) in the PIVENS, but not in the TONIC trial. There was no significant association between CYP4F2 genotypes and histological end points in either trial. Our study suggested the a moderate role of CYP4F2 polymorphisms in affecting the pharmacokinetics of Vit E as a therapeutic agent. In addition, there may be age-dependent relationship between CYP4F2 genetic variability and Vit E pharmacokinetics in NAFLD.
Rights Statement
Additional Information
  • description.provenance : Made available in DSpace on 2014-06-16T20:12:57Z (GMT). No. of bitstreams: 3 license_rdf: 1089 bytes, checksum: 0a703d871bf062c5fdc7850b1496693b (MD5) TraberMaretPublicHealthHumanSciencesResponseAdultsChildren.pdf: 532314 bytes, checksum: d721e48a53dc5d49cda28bb4130eee19 (MD5) TraberMaretPublicHealthHumanSciencesResponseAdultsChildren_SupportingInformation.zip: 42624 bytes, checksum: 20d32e05ceeeee412fe66e6c719d5bef (MD5) Previous issue date: 2014-04-23
  • description.provenance : Submitted by Erin Clark (erin.clark@oregonstate.edu) on 2014-06-16T20:12:37Z No. of bitstreams: 3 license_rdf: 1089 bytes, checksum: 0a703d871bf062c5fdc7850b1496693b (MD5) TraberMaretPublicHealthHumanSciencesResponseAdultsChildren.pdf: 532314 bytes, checksum: d721e48a53dc5d49cda28bb4130eee19 (MD5) TraberMaretPublicHealthHumanSciencesResponseAdultsChildren_SupportingInformation.zip: 42624 bytes, checksum: 20d32e05ceeeee412fe66e6c719d5bef (MD5)
  • description.provenance : Approved for entry into archive by Erin Clark(erin.clark@oregonstate.edu) on 2014-06-16T20:12:57Z (GMT) No. of bitstreams: 3 license_rdf: 1089 bytes, checksum: 0a703d871bf062c5fdc7850b1496693b (MD5) TraberMaretPublicHealthHumanSciencesResponseAdultsChildren.pdf: 532314 bytes, checksum: d721e48a53dc5d49cda28bb4130eee19 (MD5) TraberMaretPublicHealthHumanSciencesResponseAdultsChildren_SupportingInformation.zip: 42624 bytes, checksum: 20d32e05ceeeee412fe66e6c719d5bef (MD5)